Research Outputs (86)

Sort by: Date | Title

10 | 25 | 50 | 100

1/2

A B C D E F G H I J K L M N O P R S T V W All

Activation and expansion of natural killer cells from liver cancer patients
Siu Tim Cheung, Phyllis F.Y. Cheung Charing C.N. Chong, Stephen L. Chan, Anthony W.H. Chan ( 2016 )
Other conference paper
Adjuvant TS‐1 chemotherapy for Chinese patients with gastric cancer ‐ Assessment of tolerability and associated factors
Winnie Yeo, Ka O Lam, Ada LY Law, Conrad CY Lee, Chi L Chiang, Kwok H Au, Frankie KF Mo, Tsz H So, Wai T Ng, Leung Li, Kwok C Lam ( 2016 )
Invited conference paper presented and published in conference proceedings
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
Park K, Tan EH, O'Byrne K, Zhang L, Boyer M, Mok T, Hirsh V, Yang JCH, Lee KH, Lu S, Shi Y, Kim SW, Laskin J, Kim DW, Arvis CD, Kolbeck AK, Laurie SA, Tsai CM, Shahidi M, Kim M, Massey D, Zazulina V, Paz-Ares L ( 2016 )
LANCET ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S1470-2045(16)30033-X
ALK FISH Positivity and Crizotinib Efficacy in Patients (pts) with Non-Small Cell Lung Cancer (NSCLC)
SORIA Jean Charles, HO Steffan N, VARELLA GARCIA Marileila, IAFRATE A A John, SOLOMON Benjamin J, SHAW Alice T, BLACKHALL Fiona Helen, MOK Shu Kam Tony, WU Yi Long, PESTOVA Ekaterina, SIEBERT Fred W, WILNER Keith D, POLLI Anna, PAOLINI Jolanda, LANZALONE Silvana, GREEN Stephanie J, CAMIDGE D Ross ( 2016 )
ASCO 2016 Annual Meeting
Invited conference paper presented and published in conference proceedings
Amide proton transfer (APT) imaging in head and neck cancer: preliminary results'
LAW King Hong Benjamin, KING Ann Dorothy, BHATIA Kunwar Suryaveer Singh, AHUJA Anil Tejbhan, MA Buig Yue Brigette, YEUNG Kw David, WANG Yixiang, YUAN Jing ( 2016 )
24th ISMRM Annual Meeting and Exhibition
Refereed conference paper presented and published in conference proceedings
Anergic natural killer cells in liver cancer patients: ex vivo expansion and activation
Siu Tim Cheung, Phyllis F.Y. Cheung, Charing C.N. Chong, Stephen L. Chan, Anthony W.H. Chan ( 2016 )
Other conference paper
A new prognostic histopathologic classification of nasopharyngeal carcinoma
Wang HY, Chang YL, To KF, Hwang JS, Mai HQ, Feng YF, Chang ET, Wang CP, Kam MK, Cheah SL, Lee M, Gao L, Zhang HZ, He JH, Jiang H, Ma PQ, Zhu XD, Zeng L, Chen CY, Chen G, Huang MY, Fu S, Shao Q, Han AJ, Li HG, Shao CK, Huang PY, Qian CN, Lu TX, Li JT, Ye W, Ernberg I, Ng HK, Wee JT, Zeng YX, Adami HO, Chan AT, Shao JY ( 2016 )
Publication in refereed journal
View Full-text in CUHK:
40880_2016_Article_103.pdf
Digital Object Identifier (DOI): http://dx.doi.org/10.1186/s40880-016-0103-5
An update on the pharmacodynamics, pharmacokinetics, safety and clinical efficacy of nivolumab in the treatment of solid cancers
Ashley CY Wong, Brigette Ma ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1080/17425255.2016.1223047
Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma
Chan A.W.H., Chong C.C.N., Mo F.K.F., Wong J., Yeo W., Johnson P.J., Yu S., Lai P.B.S., Chan A.T.C., To K.-F., Chan S.L. ( 2016 )
Journal of Gastroenterology and Hepatology (Australia)
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1111/jgh.13339
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma
MOK Shu Kam Tony, GEATER Sarayut Lucien, SU Wu Chou, TAN Eng Huat, YANG James Chi Hsin, CHANG Gee Chen, HAN May, KOMARNITSKY Philip, PAYUMO Francis, GARRUS Jennifer E, CLOSE Sandra, PARK Keunchil ( 2016 )
Annals of Oncology
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.jtho.2016.05.038
A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma
Mok TSK, Geater SL, Su WC, Tan EH, Yang JCH, Chang GC, Han M, Komarnitsky P, Payumo F, Garrus JE, Close S, Park K ( 2016 )
JOURNAL OF THORACIC ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.jtho.2016.05.038
Are we ready for immune checkpoint inhibitors for advanced non-small-cell lung cancer?
Mok TSK, Loong HH ( 2016 )
LANCET
Publication in policy or professional journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S0140-6736(15)01308-2
Awareness, Understanding, and Adoption of Precision Medicine to Deliver Personalized Treatment for Patients With Cancer: A Multinational Survey Comparison of Physicians and Patients
Ciardiello F, Adams R, Tabernero J, Seufferlein T, Taieb J, Moiseyenko V, Ma B, Lopez G, Vansteenkiste JF, Esser R, Tejpar S ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1634/theoncologist.2015-0279
Axitinib in recurrent or metastatic nasopharyngeal carcinoma (NPC): final result of a phase 2 clinical trial with pharmacokinetic (PK) correlation
Hui EP, Ma BB, Mo F, Kam MK, Chan SL, Loong HH, Ho R, Leung SF, King AD, Wang K, Ahuja A, Chan CM, Hui CW, Wong CH, Chan ATC. ( 2016 )
Refereed conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdw 376.13
Being molecular in the molecular age
Raghupathy R, Mok T ( 2016 )
ANNALS OF ONCOLOGY
Publication in policy or professional journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdw002
Cancer Genomics: Diversity and Disparity Across Ethnicity and Geography
Tan DSW, Mok TSK, Rebbeck TR ( 2016 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2015.62.0096
Changes in cardiovascular risk profiles among young Chinese patients with breast cancer after adjuvant chemotherapy (European Journal of Cancer 57, suppl. 2 (2016)S134)
YEO Winnie, MO Kwok Fai, SUEN J, PANG Elizabeth Summing, YIP C, LEE K, LIEM G ( 2016 )
Refereed conference paper presented and published in conference proceedings
Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital
William WK Yeung, Brigette BY Ma, Janet FY Lee, Simon SM Ng, Michael HY Cheung, WM Ho, Maverick WK Tsang, Simon Chu, Daisy CM Lam, Frankie KF Mo ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.12809/hkmj154788
Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review
Ahn MJ, D'Cruz A, Vermorken JB, Chen JP, Chitapanarux I, Dang HQT, Guminski A, Kannarunimit D, Lin TY, Ng WT, Park KU, Chan ATC ( 2016 )
ORAL ONCOLOGY
Publication in refereed journal
View Full-text in CUHK:
1-s2.0-S1368837515003978-main.pdf
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.oraloncology.2015.11.019
Comments on "Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients"
Sang W, Chan SL, Chan AW ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.ejca.2016.08.023
Cost-effectiveness of pembrolizumab compared to ipilimumab and chemotherapy as a first line treatment for patients with advanced melanoma in Hong Kong
HH Loong, CKH Wong, LKS Leung, MTK Leung, J Wang, K Stevinson ( 2016 )
Invited conference paper presented and published in conference proceedings
Crizotinib vs Chemotherapy in ALK+ Advanced Non-Small Cell Lung Cancer (NSCLC): Final Survival Results from PROFILE 1007
MOK Shu Kam Tony, SHAW Alice Tsang, JANNE Pasi A, BESSE Benjamin, SOLOMON Benjamin J, BLACKHALL Fiona Helen, CAMIDGE D Ross, HIRSH Vera, SCRANTON Judith Robin, POLLI Anna, TANG Yiyun, WILNER Keith D, KIM Dong Wan ( 2016 )
ASCO 2016 Annual Meeting
Invited conference paper presented and published in conference proceedings
DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells
Xiang T, Fan Y, Li C, Li L, Ying Y, Mu J, Peng W, Feng Y, Oberst M, Kelly K, Ren G, Tao Q. ( 2016 )
Publication in refereed journal
View Full-text in CUHK:
DACT2 silencing by promoter.pdf
Digital Object Identifier (DOI): http://dx.doi.org/10.18632/oncotarget.12341
Determinants of participation in colorectal cancer screening among community-dwelling Chinese older people: Testing a comprehensive model using a descriptive correlational study
Leung DYP, Wong EML, Chan CWH ( 2016 )
EUROPEAN JOURNAL OF ONCOLOGY NURSING
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.ejon.2015.11.004
Diffusion-Weighted Imaging of Nasopharlingeal Carcinoma: Can Pretreatment DWI Predict Local Failure Based on Long-Term Outcome?
Law BKH, King AD, Bhatia KS, Ahuja AT, Kam MKM, Ma BB, Ai QY, Mo FKF, Yuan J, Yeung DKW ( 2016 )
AMERICAN JOURNAL OF NEURORADIOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.3174/ajnr.A4792
Diffusion-weighted imaging of nasopharyngeal carcinoma: Can pretreatment DWI predict local failure based on long-term outcome?
Law B.K.H., King A.D., Bhatia K.S., Ahuja A.T., Kam M.K.M., Ma B.B., Ai Q.Y., Mo F.K.F., Yuan J., Yeung D.K.W. ( 2016 )
American Journal of Neuroradiology
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.3174/ajnr.A4792
Dyslipidaemias after adjuvant chemotherapy in young Chinese breast cancer patients
W Yeo, F Mo, J Suen, H Loong, E Pang, C Yip, GS Liem ( 2016 )
Invited conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdw364.57
Dysregulated expression of arginine metabolic enzymes in human intestinal tissues of necrotizing enterocolitis and response of CaCO2 cells to bacterial components
Leung KT, Chan KYY, Ma TPY, Yu JWS, Tong JHM, Tam YH, Cheung HM, To KF, Lam HS, Lee KH, Li KR, Ng PC ( 2016 )
JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.jnutbio.2015.10.010
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
Yang JCH, Sequist LV, Zhou C, Schuler M, Geater SL, Mok T, Hu CP, Yamamoto N, Feng J, O'Byrne K, Lu S, Hirsh V, Huang Y, Sebastian M, Okamoto I, Dickgreber N, Shah R, Marten A, Massey D, Wind S, Wu YL ( 2016 )
ANNALS OF ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdw322
Epidemiology, real world treatment and outcomes of 423 patients (pts) with angiosarcoma (AS) in Asia: A report from the Asian Sarcoma Consortium (ASC)
R Quek, HH Loong, V Sriuranpong, M Farid, SH Tan, WL Goh, S Mingmalairak, TW-W Chen, CC Chang, A Pang, S Teo, ME Puhaindran, MM Maw, R Ngan, AKC Leung, JC Chan, T Hirose, M Endo, A Kawai ( 2016 )
Invited conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdw597
Epigenetic identification, of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway
Fan Y, Zhan Q, Xu HY, Li LL, Li C, Xiao Q, Xiang SL, Hui TL, Xiang TX, Ren GS ( 2016 )
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.bbrc.2016.04.146
Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers
Li LL, Li C, Mao HT, Du ZF, Chan WY, Murray P, Luo B, Chan ATC, Mok TSK, Chan FKL, Ambinder RF, Tao Q ( 2016 )
SCIENTIFIC REPORTS
Publication in refereed journal
View Full-text in CUHK:
srep26591.pdf
Digital Object Identifier (DOI): http://dx.doi.org/10.1038/srep26591
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, Aranda Aguilar E, Bardelli A, Benson A, Bodoky G, Ciardiello F, D'Hoore A, Diaz-Rubio E, Douillard JY, Ducreux M, Falcone A, Grothey A, Gruenberger T, Haustermans K, Heinemann V, Hoff P, Köhne CH, Labianca R, Laurent-Puig P, Ma B, Maughan T, Muro K, Normanno N, Österlund P, Oyen WJ, Papamichael D, Pentheroudakis G, Pfeiffer P, Price TJ, Punt C, Ricke J, Roth A, Salazar R, Scheithauer W, Schmoll HJ, Tabernero J, Taïeb J, Tejpar S, Wasan H, Yoshino T, Zaanan A, Arnold D ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1093/annonc/mdw235
Evolving Evidence of the Efficacy and Safety of nab-Paclitaxel in the Treatment of Cancers with Squamous Histologies
Loong HH, Chan ACY, Wong ACY ( 2016 )
JOURNAL OF CANCER
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.7150/jca.12986
First-line Afatinib (A) vs Gefitinib (G) for Patients (pts) with EGFR Mutation Positive (EGFRm+) NSCLC (LUX-Lung 7): Patient-reported Outcomes (PROs) and Impact of Dose Modifications on Efficacy and Adverse Events (AEs)
HIRSH Vera, YANG James Chih Hsin, TAN Eng Huat, O BYRNE Ken, ZHANG Li, BOYER Michael J, MOK Shu Kam Tony, LEE Ki Hyeong, LU Shun, SHI Yuankai, KIM Sang We, LASKIN Janessa J, KIM Dong Wan, ARVIS Catherine Dubos, KOLBECK Karl, SCHULER Martin H, MASSEY Dan, MAERTEN Angela, PAZ ARES Luis, PARK Keunchil ( 2016 )
ASCO 2016 Annual Meeting
Invited conference paper presented and published in conference proceedings
First-Line Afatinib versus Chemotherapy in Patients with Non-Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases
Schuler M, Wu YL, Hirsh V, O'Byrne K, Yamamoto N, Mok T, Popat S, Sequist LV, Massey D, Zazulina V, Yang JCH ( 2016 )
JOURNAL OF THORACIC ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.jtho.2015.11.014
First-Line Afatinib versus Gefitinib in EGFRm+ Advanced NSCLC: Updated Overall Survival Analysis of LUX-Lung 7
Keunchil Park, Eng Huat Tan, Li Zhang, Vera Hirsh, Ken O'Byrne, Michael Boyer, James Chih-Hsin Yang, Tony Mok, Ki Hyeong Lee, Shun Lu, Yuankai Shi, Sang-We Kim, Janessa Laskin, Dong-Wan Kim, Scott Laurie, Karl Kölbeck, Jean Fan, Nigel Dodd, Angela Märten, Luis Paz-Ares ( 2016 )
Invited conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.jtho.2016.11.363
First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 Study
Yang JCH, Srimuninnimit V, Ahn MJ, Lin CC, Kim SW, Tsai CM, Mok T, Orlando M, Puri T, Wang X, Park K ( 2016 )
JOURNAL OF THORACIC ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/j.jtho.2015.11.008
Gemcitabine: a game changer in nasopharyngeal carcinoma
Chua MLK, Chan ATC ( 2016 )
LANCET
Other outputs
Digital Object Identifier (DOI): http://dx.doi.org/10.1016/S0140-6736(16)31394-0
Goal adjustment influence on psychological well-being following advanced breast cancer diagnosis
Lam WWT, Yeo W, Suen J, Ho WM, Tsang J, Soong I, Yau TK, Wong KY, Sze WK, Ng AWY, Kwong A, Suen D, Fong D, Ho S, Fielding R ( 2016 )
PSYCHO-ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1002/pon.3871
Hepatotoxicity of targeted therapy for cancer
Kirsty Wai-Chung Lee, Stephen Lam Chan ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1080/17425255.2016.1190831
High-density lipoprotein cholesterol as a predictor of poor survival in patients with nasopharyngeal carcinoma
Liu Y.Y., Lin S.J., Chen Y.Y., Liu L.N., Bao L.B., Tang L.Q., Ou J.S., Liu Z.G., Chen X.Z., Xu Y., Ma J., Chan A.T., Chen M., Xia Y.F., Liu W.L., Zeng Y.X., Mai H.Q., Zeng M.S., Pan J.J., Zhang X. ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.18632/oncotarget.7160
Homing and engraftment of human hematopoietic stem/progenitor cells are regulated by R4 RGS family proteins
Wong YT, Li CK, Chan KY, Ng PC, Li K, Leung TF, Leung KT ( 2016 )
Refereed conference paper presented and published in conference proceedings
Incidence of hyperlipidemias among premenopausal Chinese breast cancer patients after adjuvant cytotoxic chemotherapy
W Yeo ( 2016 )
Invited conference paper presented and published in conference proceedings
Digital Object Identifier (DOI): http://dx.doi.org/10.4172/1948-5956.C1.086
Infection and Cancer: The Case of Hepatitis B
Chan SL, Wong VWS, Qin SK, Chan HLY ( 2016 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2015.61.5724
Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma
Chan AWH, Kumada T, Toyoda H, Tada T, Chong CCN, Mo FKF, Yeo W, Johnson PJ, Lai PBS, Chan ATC, To KF, Chan SL ( 2016 )
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1111/jgh.13291
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014
Solomon BJ, Cappuzzo F, Felip E, Blackhall FH, Costa DB, Kim DW, Nakagawa K, Wu YL, Mekhail T, Paolini J, Tursi J, Usari T, Wilner KD, Selaru P, Mok TSK ( 2016 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1200/JCO.2015.63.5888
Jagged 2 silencing inhibits motility and invasiveness of colorectal cancer cell lines
Wan He, Charles Ming Lok Chan, Sze Chuen Cesar Wong, Thomas Chi Chuen Au, Wing Shan Ho, Amanda Kit Ching Chan, Andrew Sai Kit Chan, Brigette Buig Yue Ma, Anthony Tak Cheung Chan ( 2016 )
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.3892/ol.2016.5321
KEYNOTE-122: Phase 2 study of pembrolizumab versus standard-of-care chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal carcinoma
Chan ATC, Lee V, Ngan R, To KF, Ahn MJ, Ng QS, Hong RL, Lin JC, Swaby RF, Gause C, Saraf S, Spreafico A ( 2016 )
ANNALS OF ONCOLOGY
Other outputs
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade
Toyoda H, Lai PBS, O'Beirne J, Chong CC, Berhane S, Reeves H, Manas D, Fox RP, Yeo W, Mo F, Chan AWH, Tada T, Inarrairaegui M, Vogel A, Schweitzer N, Chan SL, Sangro B, Kumada T, Johnson PJ ( 2016 )
BRITISH JOURNAL OF CANCER
Publication in refereed journal
Digital Object Identifier (DOI): http://dx.doi.org/10.1038/bjc.2016.33

10 | 25 | 50 | 100

1/2

Research Outputs (86)

Share Link

Our policy towards the use of cookies